ACAD
30
-3
-9.09%
AEMD
5.1
-0.06
-1.16%
APRI
0.47
-0.03
-5.11%
ARNA
1.62
-0.09
-5.26%
ATEC
0.23
+0.01
+2.22%
CNAT
2.68
-0.04
-1.47%
CRXM
0.19
0.00
0.00%
CYTX
0.271
-0.029
-9.8033%
DXCM
63.08
-2.02
-3.10%
GNMK
5.7
-0.14
-2.40%
HALO
10.22
-0.63
-5.81%
ILMN
133.65
-2.27
-1.67%
INNV
0.086
0.00
0.00%
INO
10.36
-0.52
-4.78%
ISCO
3.73
+0.01
+0.27%
ISIS
57.56
0.00
0.00%
LGND
119.9
-3.12
-2.54%
LPTN
0.25
+0.03
+16.28%
MBVX
0.66
0.00
0.00%
MEIP
1.42
-0.02
-1.39%
MNOV
6.84
-0.16
-2.29%
MRTX
20.21
-1.34
-6.22%
MSTX
0.319
+0.029
+9.962%
NBIX
45.05
-1.66
-3.55%
NUVA
52.16
-0.45
-0.86%
ONCS
1.82
-0.06
-3.19%
ONVO
2.71
-0.12
-4.24%
OREX
0.462
-0.005
-1.0493%
OTIC
13.84
-0.12
-0.86%
QDEL
16.92
-0.26
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
5.44
-0.49
-8.26%
RMD
55.64
-0.49
-0.87%
SPHS
1.41
+0.07
+5.22%
SRNE
6.83
-0.15
-2.15%
TROV
3.75
-0.24
-6.02%
VICL
0.38
0.00
-0.05%
VOLC
18
0.00
0.00%
ZGNX
10.28
-0.05
-0.48%
ACAD
30
-3
-9.09%
AEMD
5.1
-0.06
-1.16%
APRI
0.47
-0.03
-5.11%
ARNA
1.62
-0.09
-5.26%
ATEC
0.23
+0.01
+2.22%
CNAT
2.68
-0.04
-1.47%
CRXM
0.19
0.00
0.00%
CYTX
0.271
-0.029
-9.8033%
DXCM
63.08
-2.02
-3.10%
GNMK
5.7
-0.14
-2.40%
HALO
10.22
-0.63
-5.81%
ILMN
133.65
-2.27
-1.67%
INNV
0.086
0.00
0.00%
INO
10.36
-0.52
-4.78%
ISCO
3.73
+0.01
+0.27%
ISIS
57.56
0.00
0.00%
LGND
119.9
-3.12
-2.54%
LPTN
0.25
+0.03
+16.28%
MBVX
0.66
0.00
0.00%
MEIP
1.42
-0.02
-1.39%
MNOV
6.84
-0.16
-2.29%
MRTX
20.21
-1.34
-6.22%
MSTX
0.319
+0.029
+9.962%
NBIX
45.05
-1.66
-3.55%
NUVA
52.16
-0.45
-0.86%
ONCS
1.82
-0.06
-3.19%
ONVO
2.71
-0.12
-4.24%
OREX
0.462
-0.005
-1.0493%
OTIC
13.84
-0.12
-0.86%
QDEL
16.92
-0.26
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
5.44
-0.49
-8.26%
RMD
55.64
-0.49
-0.87%
SPHS
1.41
+0.07
+5.22%
SRNE
6.83
-0.15
-2.15%
TROV
3.75
-0.24
-6.02%
VICL
0.38
0.00
-0.05%
VOLC
18
0.00
0.00%
ZGNX
10.28
-0.05
-0.48%
Home » Events

SDBDG BioTalk: Nuvasive

Submitted by on December 29, 2008 – 9:17 am

San Diego Biotechnology Discussion Group’s January BioTalk: Nuvasive, January 28, 2009, 5:30-8:00 p.m., Sorrento Summit (adjacent to Nuvasive HQ)

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Please prove you\'re human, solve this: *